Search
Add Trial
Sign In
NSCLC - Non Small Cell Lung Cancer Now Closed

CCTG BR.31 - Hosted By

0
Add Review Viewed - 1311
Save Bookmark
Print
HomeNSCLC - Non Small Cell Lung CancerCCTG BR.31
Sponsor Name
Tumor Site NSCLC - Non Small Cell Lung Cancer
Disease Stage Stage I, Stage II, Stage III
Clinical Status Adjuvant, Operable
Phase Phase III
Intervention / Treatment Durvalumab versus Placebo
Research Site Montreal, QC, Montreal University Hospital Center
Investigator Dr Moishe Liberman
Telephone Number +1 (514) 890-8000
Study Start Date October 9, 2014
Study End Date January 1, 2023
Trial Status Recruitment

Tags

NCT02273375

Working Hours :

Now Closed UTC - 5
  • MondayDay Off
  • TuesdayDay Off
  • WednesdayDay Off
  • ThursdayDay Off
  • FridayDay Off
  • SaturdayDay Off
  • SundayDay Off

Price / Claim :

Own or work here? Claim Now!

Recruit a patient:

*for confidentiality, do not include the name of the patient

*pour raisons de confidentialité, n'incluez pas le nom du patient

Hosted by :

elie
View Profile

Claim listing: CCTG BR.31

✕

Our website is under development. We're sorry for any inconvenience that might appear.Notre site web est en cours de développement. Nous sommes désolés pour tout inconvénient qui pourrait survenir.

Reply to Message

Sign In KANCEL

Lost Your Password?

Please select an account type above.

Account details will be confirmed via email.

Register with us by filling out the form below.
Register with us by filling out the form below.

Reset Your Password